Publications by authors named "Marco Robello"

Claim this Profile
S
Sulfanylbenzamides with Unique Side Chains to Improve Metabolic Stability, Pharmacokinetics, and Anti-HIV Activity.
Marco Robello, Riley F Lehman, Daniel H Appella

J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Covalent Modification of p53 by ()-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one.
Kate Brown, Marco Robello, Andrew J Perciaccante, Jerry C Dinan, Tapan K Maity

ACS Pharmacol Transl Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodrug Strategy Extends the Use of Anti-HIV Sulfanylbenzamides for Application .
Marco Robello, Herman Nikolayevskiy, Michael T Scerba, Rogers Alberto Nahui Palomino, Vincenzo Mercurio

ACS Pharmacol Transl Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.
Elisabetta Barresi, Marco Robello, Emma Baglini, Valeria Poggetti, Monica Viviano

Pharmaceuticals (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkyl-substituted N-methylaryl-N'-aryl-4-aminobenzamides: A new series of small molecule inhibitors for Wip1 phosphatase.
Marco Robello, Hongchao Zheng, Mrinmoy Saha, Kara M George Rosenker, Subrata Debnath

Eur J Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: Synthesis and pharmacological effects.
Marco Robello, Silvia Salerno, Elisabetta Barresi, Paola Orlandi, Francesca Vaglini

Arch Pharm (Weinheim)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.
Marco Robello, Elisabetta Barresi, Emma Baglini, Silvia Salerno, Sabrina Taliani

J Med Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.
Emma Baglini, Silvia Salerno, Elisabetta Barresi, Marco Robello, Federico Da Settimo

Eur J Pharm Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update into the medicinal chemistry of translocator protein (TSPO) ligands.
Elisabetta Barresi, Marco Robello, Barbara Costa, Eleonora Da Pozzo, Emma Baglini

Eur J Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The structure-activity profile of mercaptobenzamides' anti-HIV activity suggests that thermodynamics of metabolism is more important than binding affinity to the target.
Herman Nikolayevskiy, Marco Robello, Michael T Scerba, Evan H Pasternak, Mrinmoy Saha

Eur J Med Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases.
Silvia Salerno, Valeria La Pietra, Mariafrancesca Hyeraci, Sabrina Taliani, Marco Robello

Eur J Med Chem· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A and A adenosine receptor subtypes.
Elisabetta Barresi, Chiara Giacomelli, Simona Daniele, Ilaria Tonazzini, Marco Robello

Bioorg Med Chem· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residence Time, a New parameter to Predict Neurosteroidogenic Efficacy of Translocator Protein (TSPO) Ligands: the Case Study of N,N-Dialkyl-2-arylindol-3-ylglyoxylamides.
Barbara Costa, Sabrina Taliani, Eleonora Da Pozzo, Elisabetta Barresi, Marco Robello

ChemMedChem· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas.
Simona Daniele, Valeria La Pietra, Elisabetta Barresi, Salvatore Di Maro, Eleonora Da Pozzo, Marco Robello

J Med Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward PET imaging of A2B adenosine receptors: a carbon-11 labeled triazinobenzimidazole tracer: Synthesis and imaging of a new A2B PET tracer.
Debora Petroni, Chiara Giacomelli, Sabrina Taliani, Elisabetta Barresi, Marco Robello

Nucl Med Biol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis